Escolar Documentos
Profissional Documentos
Cultura Documentos
The old stages showed a broader range of rates than the new stages. The best model fit, as measured by the AIC, was achieved for the old model.
Others methodological aspects of the study were published previously [ 5 ]. This trial is especially suitable for this purpose, not only because of its
duration, but also because of its size almost 6, patients randomized , international origin, and high quality-controlled lung function data. We would
like to thank Astra-Zeneca for their financial support of this study. The presence of comorbidities was evaluated by the Charlson index [ 9 ].
Second, few women were included in the cohort, and the findings reported here cannot be extended to that gender. This is the largest amount of
air you can breathe out after breathing in as deeply as you can. Symptoms, lung function and exacerbation history were all related to the
exacerbation rates. However, this concordance improved around 0. The exacerbation rate increased with disease severity in both the old and the
new system. These results have four grades, too:. Table 3 Weibull models for mortality. Negative binomial regression with adjustment for treatment
exposure was applied to analyse the total rate of exacerbations. This value was found by Han et al. Time to death was analysed in Weibull
regression models, with either the old or new GOLD classification as covariates as well as other prognostic factors. The rates in the new
classification covered a broader range than the rates in the old stages and the new classification system had a much better AIC than the old system.
Conclusions The new classification system is a modest step towards a phenotype approach. Create Presentation Download Presentation. Health-
related quality of life is associated with COPD severity: The largest group is formed by patients in stage D. Rosa Irigaray, Hospital de Manacor,
Manacor. Little differences were found by groups, though we observed greater variability for group C and lower variability for group D. In ,
GOLD presented a new classification system, which was adapted slightly in [ 8 ]. A generalized linear model was used to compare the numbers of
exacerbations total and severe per stage. Patients were assigned to substages based on the reason for being considered high-risk: The analyses
were performed and the first draft of the manuscript was written by an academic investigator. For severe exacerbations, the best fit was achieved
by models with the new system with the new classification system with substages. A new method of classifying prognostic comorbidity in
longitudinal studies: The number of different types of respiratory medications and the number of courses of antibiotics and oral steroids in the year
before randomisation increased from A through D. Lung function decline Lung function decline, expressed as the deteriorating course of post-
bronchodilator FEV 1 , was analysed in a linear random effects model. Little is known about the longitudinal changes associated with using the
update of the multidimensional GOLD strategy for chronic obstructive pulmonary disease COPD. Revisiting and Evaluating Classification
Accuracy -Significance: Surveillance for respiratory hazards in the occupational setting. Does the GOLD classification improve the ability to predict
lung function decline, exacerbations and mortality: Patients were assessed at randomisation, after one month, six months, and every six months
thereafter. Earlier studies compared the predictive performance of new and old classification systems with regards to mortality and exacerbations.
However, Lange et al. He has never been intubated, but gets about 3 exacerbations per year. In fact, the authors note that updates of the
guidelines may include other scales. Currently, the importance of these annual changes by grade remains unknown. All of them can make you feel
breathless. The results of the sensitivity analyses are presented in the Additional file 1. In addition, the main results remain unchanged when we
performed a stratified subanalysis of the population by gender. However, this previous study evaluated the temporal stability after 3 years and only
used the mMRC for symptom assessment [ 3 ]. Exacerbations and hospitalisations were predicted better by the new system according to Lange et
al. The individual predictions per disease stage were then averaged over all patients. In a personal interview, trained staff obtained the following
information at the time of recruitment and at yearly appointments: Global initiative for chronic obstructive lung disease mMRC: Combining patients
with a low lung function and history of frequent exacerbations into the same stages hides the major differences between these patients. Similarly as
to what was found in the base case analysis, all three mortality models had very similar c-statistics Additional file 1: For the previous GOLD stages
24, survival curves were clearly separated. Am Rev Respir Dis. The aim of this study, therefore, was to compare the ability of the old and the
new i. Patients from stage 2 were classified into all four new stages, with the majority in B. The clinical application of the new GOLD classification
in the clinical practice remains unclear and more data with this proposed approach are needed. More information about our cookie policy Close.
Using trial data for a study like this has advantages and disadvantages. After this, mean survival probabilities per 6-month interval were calculated
over all patients for each stage and each point in time. The patients in C and D categories walked less, had a higher BODE index and received
more pulmonary pharmacological therapy.